Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer

18 views

Published on

Bradley J. Monk, MD, FACS, FACOG, and Lyndsay J. Willmott, MD, discuss ovarian cancer in this CME/MOC activity titled "Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer." For the full presentation, downloadable Practice Aids, monograph, complete CME/MOC information, and to apply for credit, please visit us at http://bit.ly/2U8wkob. CME/MOC credit will be available until April 29, 2021.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

×